Merit Medical Systems shares rose after the company said it expects sales to come in ahead of Wall Street expectations and it chose a new chief executive to replace its founder and long-time head. The ...

FactSet reports Q3 2025 revenues of $585.5 million, CEO transition, and a decline in operating margins and EPS. FactSet reported its financial results for the third quarter of fiscal 2025 ...

FactSet reports solid Q3 FY25 results with revenue/user growth and strong acquisitions. Discover why it’s a Buy with a $490 fair value estimate.

FactSet appointed Sanoke Viswanathan as CEO, effective early September 2025. He succeeds Phil Snow, who will retire as CEO and Board member.

Merit Medical Systems appointed Martha Aronson as chief executive and president and is expecting higher-than-projected sales in the second quarter. Aronson will step in on Oct. 3 succeeding Fred ...

Q3 2025 Management View CEO Frederick Philip Snow opened by announcing his retirement after 30 years with FactSet and a ...

Shares of FactSet Research Systems were among the top gainers on the S&P 500 Monday after the financial data provider ...

FactSet announced that Phil Snow will retire as CEO and a member of the Board, effective early September 2025 and will be succeeded by Sanoke Viswanathan, most recently CEO of International Consumer ...

GAAP revenues increased 5.9%, or $32.8 million, to $585.5 million for the third quarter of fiscal 2025 compared with $552.7 million in the prior year period. Organic (1) revenues grew 4.4% year ...

Q3 2025 Earnings Call Transcript June 23, 2025 FactSet Research Systems Inc. misses on earnings expectations. Reported EPS is $4.27 EPS, expectations were $4.3. Operator: Good day and welcome to the ...

FactSet Research Systems (FDS) stock gained after Q3 results. Qtrly adjusted EPS of $4.27, missing street view of $4.29. Sales of $585.52M topped estimates of $580.50M. Organic rev up 4.4%.